R&D expenses of Moderna 2016-2024

Published by
Matej Mikulic,
Mar 24, 2025

The statistic illustrates the research and development expenses of Moderna Inc. between 2016 and 2024. Moderna spent around 4.5 billion U.S. dollars on R&D in 2024, a similar amount to the previous year. The company became widely known for being one of two companies worldwide which had their COVID-19 vaccine approved already in late 2020.

Research and development expenses of Moderna Inc. from 2016 to 2024 (in million U.S. dollars)

CharacteristicExpense in million U.S. dollars
2024 4,543
2023 4,845
2022 3,295
2021 1,991
2020 1,370
2019 496
2018 454
2017 411
2016 275
Showing entries 1 to 9 (9 entries in total)
Created with Highcharts 7.2.2Expense in million U.S. dollars2752754114114544544964961,3701,3701,9911,9913,2953,2954,8454,8454,5434,543201620172018201920202021202220232024

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2025

Region

Worldwide, United States

Survey time period

2016 to 2024

Open this statistic in...
Spanish
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom

Related reports: Available to download in PDF or PPTX format

All datain one format
All data
in one format
mRNA technology
  • 38 page/s
  • English
  • pptx
  • Detailed references

Everything on "mRNA technology" in one document: edited and divided into chapters, including detailed references.

Go to report
Further reports
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Moderna Inc. "

Other statistics that may interest you Moderna Inc.

Market overview

6

Key figures

5

Competitors

4

Focus: COVID-19

8

Further related statistics

16

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

ModernaGlobal pharmaceutical industryPfizerBioNTechVaccinations in the U.S.
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.